Advanced search
Start date

Inhibition of LXR alpha phosphorylation: evaluating target gene expression effects and LXR alpha and PPAR gamma crosstalk

Grant number: 17/12314-0
Support Opportunities:Scholarships abroad - Research Internship - Master's degree
Effective date (Start): September 14, 2017
Effective date (End): January 16, 2018
Field of knowledge:Biological Sciences - Biochemistry - Chemistry of Macromolecules
Principal Investigator:Ana Carolina Migliorini Figueira
Grantee:Thaís Helena Tittanegro
Supervisor: Matthew Charles Gage
Host Institution: Centro Nacional de Pesquisa em Energia e Materiais (CNPEM). Ministério da Ciência, Tecnologia e Inovações (Brasil). Campinas , SP, Brazil
Research place: University College London (UCL), England  
Associated to the scholarship:16/13480-9 - Identification of the mechanisms of phosphorylation of PPARy and its relations with the recruitment of corepressors, BP.MS


PPARs and LXRs are lipid-activated transcription factors that belong to the nuclear receptor superfamily. Both types of receptors are activated by ligands from dietary lipids, such as fatty acids and cholesterol metabolites (oxysterols), respectively. They are intrinsically involved in metabolic pathways related to inflammation, diabetes, obesity and cardiovascular diseases, which make them potential targets for new therapeutic development. Several studies have reported the interaction between these two nuclear receptors regarding their crosstalk involved in macrophage activation, adiponectin production and vessel wall cell maintenance. Additionally, studies of animals submitted to caloric restriction have demonstrated changes in the expression profile of genes regulated by these two receptors. Moreover, it has also been shown that diets with high levels of fat and cholesterol in a novel mouse model, which have inhibited phosphorylation of LXR alpha at serine 196 residue, resulted in reduction in hepatic inflammation and fibrosis. Here we propose to study the relationship between PPAR gamma and LXR alpha expression profiles in two novel mouse models of LXR alpha phosphorylation deficiency, which are currently being used to investigate the effects of LXR alpha signalling on atherosclerosis, liver steatosis and fibrosis in which PPAR gamma is intimately linked. (AU)

News published in Agência FAPESP Newsletter about the scholarship:
Articles published in other media outlets (0 total):
More itemsLess items

Scientific publications
(References retrieved automatically from Web of Science and SciELO through information on FAPESP grants and their corresponding numbers as mentioned in the publications by the authors)
GAGE, M. C.; BECARES, N.; LOUIE, R.; WADDINGTON, K. E.; ZHANG, Y.; TITTANEGRO, T. H.; RODRIGUEZ-LORENZO, S.; JATHANNA, A.; POURCET, B.; PELLO, O. M.; et al. Disrupting LXRa phosphorylation promotes FoxM1 expression and modulates atherosclerosis by inducing macrophage proliferation. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, v. 115, n. 28, p. E6556-E6565, . (17/12314-0)

Please report errors in scientific publications list by writing to: